Llwytho...

Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma

Multiple myeloma (MM) is a cancer caused by uncontrolled proliferation of antibody-secreting plasma cells in bone marrow, which represents the second most common hematological malignancy. MM is a highly heterogeneous disease and can be classified into a spectrum of subgroups based on their molecular...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:World J Clin Oncol
Prif Awduron: Zhou, Jianbiao, Chng, Wee-Joo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Inc 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766463/
https://ncbi.nlm.nih.gov/pubmed/31572666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v10.i9.303
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!